Utama › Kanser Hati (Karsinoma Hepatoselular) › New Jersey
Kajian klinikal Kanser Hati (Karsinoma Hepatoselular) di New Jersey
10 kajian untuk Kanser Hati (Karsinoma Hepatoselular) sedang mencari peserta di lokasi di New Jersey.
Bandar di New Jersey
Teks kajian rasmi (Bahasa Inggeris)
A Study of ZW251 in Participants With Advanced Solid Tumors
- Hackensack University Medical Center, Hackensack
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT07164313Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #88, East Brunswick
- Exelixis Clinical Site #105, Hackensack
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05176483A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07291076Evaluating Novel Therapies in ctDNA Positive GI Cancers
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05482516Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Research Site, New Brunswick
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06921785First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
- Research Site, Hackensack
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT06795022A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Overlook Medical Center, Summit
Mengambil pesertaFasa 2
Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
- Rutgers Cancer Institute of New Jersey, New Brunswick
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Jan 2026 · NCT05366829SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
- Englewood Hospital, Englewood
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2025 · NCT06681818Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.